The Absorption, Metabolism and Excretion of [14C]Ensartinib in Human
Clinical trial NCT03804541 · UNKNOWN
Trial details
- NCT number
- NCT03804541
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-28
- Primary completion
- 2019-06-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.